Blogs & News

Tissue Microarray for Prostate Cancer: Accelerating Biomarker Discovery and Precision Oncology In the evolving field of oncology research,…

Tissue Microarray (TMA): The Future of Tissue-Based Research and Diagnostics In modern biomedical research, efficiency and precision define…

MYmAb Biologics Invited as Host Company for BeST Programme 2.0 We are proud to announce that MYmAb Biologics…

MYmAb Biologics Featured on CBS News: Bringing Equity to Global Cancer Innovation We are proud to share that…

How Tissue Microarrays Facilitate Tumour Microenvironment (TME) Research What is the Tumour Microenvironment (TME)? The tumour microenvironment (TME)…

MYmAb Biologics Recognized as a BioNexus Status Company March 2025 – We are thrilled to announce that MYmAb…

Tissue Microarrays (TMAs): Applications in Tumour Biology Tissue Microarrays (TMAs) have transformed cancer research, offering an innovative platform…

Tissue Microarray for Clinical Research Tissue microarray (TMA) is a cutting-edge, high-throughput technology revolutionizing the analysis of molecular…

MYmAb Biologics’ Founder, Dr. Jia-Xin Chua, Featured on Asia Business Outlook At MYmAb Biologics, we’re proud to share…

An Overview of the Different Types of Human Tissue Microarrays (TMAs) Recent advancements in cancer research have been…

Cancer Statistics in Southeast Asian Countries: Gender, Types, and More Cancer is one of the most pressing public…

Cancer Statistics in South, East & South-Eastern Asian Countries: Gender, Types, and More Cancer remains one of the…